D-0154-2020 Class III Terminated
FDA drug recall D-0154-2020 was initiated by Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center on Oct 21, 2019 and is designated Class III. Reason for recall: Incorrect labeling: Incorrect or missing lot and/or exp date The recall status is terminated (terminated May 7, 2020). Affected quantity: 19,390 syringes.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 6, 2019
- Initiation Date
- Oct 21, 2019
- Termination Date
- May 7, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 19,390 syringes
Product description
PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL), Rx Only, Single-Dose Container, 5 x 10 mL pre-filled syringes, Nephron 503B Outsourcing Facility 4500 12th St. Ext West Columbia, SC 29172, NDC 69374-919-10.
Reason for recall
Incorrect labeling: Incorrect or missing lot and/or exp date
Distribution pattern
Nationwide in the U.S.
Code information
Lots: SU9079A, SU9079B, Exp 4/5/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0154-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026